Venus Remedies Feature in BW HealthcareWorld: Driving Innovation Against Superbugs

BW HealthcareWorld has featured an expert article by Mr. Saransh Chaudhary, President – Global Critical Care at Venus Remedies and CEO of VMRC, on why metallo-β-lactamase (MBL) inhibitors are crucial in India’s fight against deadly superbugs. The piece underscores the role of innovation and collaboration in tackling antimicrobial resistance.

Venus Remedies is proud to have its critical care expertise featured in BW HealthcareWorld, where Mr. Saransh Chaudhary shares insights on combating antimicrobial resistance (AMR) through the development of metallo-β-lactamase (MBL) inhibitors. These next-generation compounds could restore the effectiveness of last-line antibiotics and address a growing public health threat in India. In the article, Mr. Chaudhary stresses the importance of innovation, regulatory alignment, and public-private collaboration to bring such breakthroughs from lab to bedside. This recognition reflects our ongoing commitment to critical care innovation and our mission to deliver impactful healthcare solutions. We will continue to carry forward this work, building the partnerships and research needed to turn the tide against superb